Agios Pharmaceuticals, Inc. (AGIO) Insider Trading
Over the last 3 months, AGIO insiders made 0 open-market buys and 2 sales, a net sale of -$1.1M (SEC Form 4). Over the last 6 months, 181 institutions increased and 151 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
2
Net (3m)
-$1.1M
Insider trades by month Buys Sells
Nov
Jan
Mar
Apr
Jul
Aug
Context3-month price +19.1%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 6, 2026 | Gheuens Sarahofficer: Chief Medical Officer | Sell | 30,000 | $30.48 |
| Jul 10, 2026 | Backstrom Jay T.director | Option | 1,447 | — |
| Jul 10, 2026 | Backstrom Jay T.director | Grant | 1,447 | — |
| Jul 2, 2026 | Gheuens Sarahofficer: Chief Medical Officer | Sell | 4,007 | $37.56 |
| Jul 2, 2026 | Gheuens Sarahofficer: Chief Medical Officer | Option | 8,375 | — |
| Jun 23, 2026 | Scadden Daviddirector | Option | 2,816 | — |
| Jun 23, 2026 | Smith Cynthiadirector | Option | 2,816 | — |
| Jun 23, 2026 | Viswanadhan Krishnanofficer: Chief Strategy and Operations | Grant | 3,000 | — |
| Jun 23, 2026 | Foster-Cheek Kaye Idirector | Grant | 14,950 | $34.16 |
| Jun 23, 2026 | FOUSE JACQUALYN Adirector | Grant | 2,927 | — |
| Jun 23, 2026 | Scadden Daviddirector | Grant | 2,927 | — |
| Jun 23, 2026 | Jones Ceciliaofficer: Chief Financial Officer | Option | 3,000 | — |
| Jun 23, 2026 | Foster-Cheek Kaye Idirector | Option | 2,816 | — |
| Jun 23, 2026 | Milanova Tsvetaofficer: Chief Commercial Officer | Grant | 3,000 | — |
| Jun 23, 2026 | Goff Briandirector, officer: Chief Executive Officer | Grant | 39,000 | — |
| Jun 23, 2026 | Viswanadhan Krishnanofficer: Chief Strategy and Operations | Option | 3,000 | — |
| Jun 23, 2026 | Gheuens Sarahofficer: Chief Medical Officer | Option | 3,000 | — |
| Jun 23, 2026 | Goff Briandirector, officer: Chief Executive Officer | Option | 39,000 | — |
| Jun 23, 2026 | Foster-Cheek Kaye Idirector | Grant | 2,927 | — |
| Jun 23, 2026 | Ho Maykindirector | Grant | 2,927 | — |
| Jun 23, 2026 | Jones Ceciliaofficer: Chief Financial Officer | Grant | 3,000 | — |
| Jun 23, 2026 | Burns James Williamofficer: Chief Legal Officer | Grant | 3,000 | — |
| Jun 23, 2026 | Scadden Daviddirector | Grant | 14,950 | $34.16 |
| Jun 23, 2026 | Ho Maykindirector | Grant | 14,950 | $34.16 |
| Jun 23, 2026 | FOUSE JACQUALYN Adirector | Option | 2,816 | — |
| Jun 23, 2026 | Backstrom Jay T.director | Grant | 14,950 | $34.16 |
| Jun 23, 2026 | Ballal Rahul D.director | Grant | 14,950 | $34.16 |
| Jun 23, 2026 | Smith Cynthiadirector | Grant | 14,950 | $34.16 |
| Jun 23, 2026 | Gheuens Sarahofficer: Chief Medical Officer | Grant | 3,000 | — |
| Jun 23, 2026 | Smith Cynthiadirector | Grant | 2,927 | — |
Source: AGIO SEC Form 4 filings, latest Aug 6, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their AGIO positions over the last 6 months (SEC Form 13F).
Increased
181
New positions
73
Reduced
151
Sold out
32
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 6.5M | Aug 7, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 5.9M | Aug 14, 2026 |
| ARMISTICE CAPITAL, LLC | Reduced | 5.9M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 5.8M | May 13, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 5.7M | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Reduced | 5.2M | Aug 14, 2026 |
| STATE STREET CORP | Increased | 3.5M | Aug 7, 2026 |
| Lynx1 Capital Management LP | Increased | 3.4M | Aug 13, 2026 |
| STATE STREET CORP | Increased | 3.4M | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Increased | 3.1M | Aug 14, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 2.9M | Aug 13, 2026 |
| ERSTE ASSET MANAGEMENT GMBH | Reduced | 2.7M | May 11, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2.7M | Aug 13, 2026 |
| D. E. SHAW & CO., INC. | Increased | 2.7M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2.6M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.